Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?
Main Authors: | Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Lin, Han-Chieh, Chiou, Yi-You, Lee, Fa-Yauh, Huo, Teh-Ia |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349891/ |
Similar Items
-
Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model
by: Hsu, Chia-Yang, et al.
Published: (2014) -
When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy
by: Liu, Po-Hong, et al.
Published: (2015) -
Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology
by: Liu, Po-Hong, et al.
Published: (2015) -
Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis
by: Liu, Po-Hong, et al.
Published: (2014) -
Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System
by: Hsu, Chia-Yang, et al.
Published: (2015)